Zinplava (bezlotoxumab) injection will be discontinued as of January 31, 2025, according to the FDA’s drug shortages tracker.

Todd Bridges is proud of the work he's put in to reach three decades of sobriety. The Diff’rent Strokes alum, 59, appeared on the latest episode of the Allison Interviews podcast and opened up about ...

Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...

I am Greek and have thalassemia minor. In general, my red blood cells are much smaller than typical ones, and my iron content ...

The panelist discusses how early detection of recurrent Clostridioides difficile infections is critical in clinical practice because these infections can rapidly escalate patient morbidity and ...

Panelist discusses how recurrent Clostridioides difficile infection results from persistent microbiome disruption, where antibiotic-induced dysbiosis enables bacterial overgrowth and toxin production.

Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and ...

LPOXY Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on innovative therapies for infectious disease ...

Although more evidence is needed, probiotics may help your immune system by creating and maintaining a healthy gut microbiome ...

Pharmaceuticals is a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

Xeno Biosciences may have been unable to prove that its drug delivering oxygen to the gastrointestinal tract can induce ...